Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus

NCT06532578 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity

Interventions

BIOLOGICAL: CPX101 or placebo 120mg Q2W
BIOLOGICAL: CPX101 or placebo 160mg Q4W
BIOLOGICAL: CPX101 or placebo 160mg Q2W
BIOLOGICAL: CPX101 or placebo 240mg Q4W
BIOLOGICAL: CPX101 or placebo 240mg Q2W
BIOLOGICAL: CPX101 or placebo 320mg Q2W
BIOLOGICAL: CPX101 or placebo 360mg Q4W

Sponsor

Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.